Minnesota Clinical Study Center

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Psoriasis4 trials
• Atopic dermatitis (eczema)2 trials
• Lichen planus2 trials
• Hidradenitis suppurativa1 trial

Phase

• Phase 39 trials
• Phase 22 trials

Status

• Active, not recruiting6 trials
• Completed3 trials
• Recruiting2 trials

Lead sponsor

• Janssen Research & Development, LLC3 trials
• Novartis Pharmaceuticals2 trials
• Acrotech Biopharma Inc.1 trial
• Incyte Corporation1 trial
• Organon and Co1 trial
• and 3 more

Running trials

• Recruiting

  A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

  NCT07775924· Phase 2· Novartis Pharmaceuticals· Source

  Contact: Madeline Thompson

• Recruiting

  Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

  NCT07637734· Phase 3· Verrica Pharmaceuticals Inc.· Source

  Contact: Project Manager

• Active, not recruiting

  A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

  NCT07265479· Phase 3· Organon and Co· Source

• Active, not recruiting

  A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis

  NCT06934226· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

  NCT06550076· Phase 3· Takeda· Source

• Active, not recruiting

  SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations

  NCT06239480· Phase 3· Palvella Therapeutics, Inc.· Source

• Active, not recruiting

  A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)

  NCT06095102· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

  NCT06095115· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lichen planus1 recruiting

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

  NCT05593432· Phase 2· Incyte Corporation· Source

• Completed

  A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

  NCT05571943· Phase 3· Acrotech Biopharma Inc.· Source

• Completed

  Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

  NCT04179175· Phase 3· Novartis Pharmaceuticals· Source